Longitudinal Data from the KETO-CTA Study: Plaque Predicts Plaque, ApoB Does Not: JACC Adv. 2025;4(7):101686.

Adrian Soto-Mota¹, Nicholas G Norwitz², Venkat S Manubolu³, April Kinninger³, Thomas R Wood⁴, James Earls⁵, David Feldman⁶, Matthew Budoff³

¹Metabolic Diseases Research Unit, National Institute for Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico; Tecnologico de Monterrey, School of Medicine, Mexico City, Mexico.

²Harvard Medical School Boston, Boston, Massachusetts, USA.

³Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.

⁴Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.

⁵Cleerly, New York, New York, USA.

⁶Citizen Science Foundation, Las Vegas, Nevada, USA.

PubMed DOI

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the authors and the Editors. Following publication, concerns were raised regarding the methodology in this article, which effect the reliability of the data. The authors and the Editors agree that the ident…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.